IMAX Corp Files Q3 2024 10-Q Report
Ticker: IMAX · Form: 10-Q · Filed: 2024-10-30T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, earnings, financials
TL;DR
IMAX Q3 2024 10-Q filed. Check financials.
AI Summary
IMAX Corp reported its third-quarter results for the period ending September 30, 2024. The company's financial statements are included in this 10-Q filing, detailing its performance and financial position. Specific financial figures and operational details are available within the document.
Why It Matters
This filing provides investors and analysts with the official financial performance data for IMAX Corp during the third quarter of 2024, crucial for evaluating the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a standard quarterly financial filing (10-Q) and does not inherently present new risks.
Key Players & Entities
- IMAX CORP (company) — Filer of the 10-Q report
- 20240930 (date) — End of the reporting period
- 20241030 (date) — Date of filing
- 0000921582 (company) — Central Index Key for IMAX Corp
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the quarter ended September 30, 2024.
When was this 10-Q filing submitted to the SEC?
This 10-Q filing was submitted on October 30, 2024.
What is the Central Index Key (CIK) for IMAX Corp?
The Central Index Key for IMAX Corp is 0000921582.
What is the fiscal year end for IMAX Corp?
IMAX Corp's fiscal year ends on December 31.
Where is IMAX Corp headquartered?
IMAX Corp is headquartered in Mississauga, Ontario, Canada.
Filing Stats: 4,573 words · 18 min read · ~15 pages · Grade level 17.8 · Accepted 2024-10-30 17:14:20
Filing Documents
- imax-20240930.htm (10-Q) — 2697KB
- exhibit311ceocertification.htm (EX-31.1) — 12KB
- exhibit312cfocertification.htm (EX-31.2) — 12KB
- exhibit321ceocertification.htm (EX-32.1) — 6KB
- exhibit322cfocertification.htm (EX-32.2) — 6KB
- imax-20240930_g1.jpg (GRAPHIC) — 2KB
- 0000921582-24-000022.txt ( ) — 14910KB
- imax-20240930.xsd (EX-101.SCH) — 103KB
- imax-20240930_cal.xml (EX-101.CAL) — 137KB
- imax-20240930_def.xml (EX-101.DEF) — 447KB
- imax-20240930_lab.xml (EX-101.LAB) — 1047KB
- imax-20240930_pre.xml (EX-101.PRE) — 751KB
- imax-20240930_htm.xml (XML) — 3072KB
FINANCIAL INFORMATION
PART I. FINANCIAL INFORMATION
Financial Statements
Item 1. Financial Statements 3
Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 40
Quantitative and Qualitative Disclosures about Market Risk
Item 3. Quantitative and Qualitative Disclosures about Market Risk 64
Controls and Procedures
Item 4. Controls and Procedures 66
OTHER INFORMATION
PART II. OTHER INFORMATION
Legal Proceedings
Item 1. Legal Proceedings 67
Risk Factors
Item 1A. Risk Factors 67
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 68
Other Information
Item 5. Other Information 69
Exhibits
Item 6. Exhibits 70
Signatures
Signatures 71 2 Table of Contents IMAX CORPORATION
FINANCIAL INFORMATION
PART I. FINANCIAL INFORMATION
Financial Statements
Item 1. Financial Statements Page The following unaudited Condensed Consolidated Financial Statements are filed as part of this Report: Condensed Consolidated Balance Sheets as of September 30, 2024 and December 31, 2023 4 Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2024 and 2023 5 Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2024 and 2023 6 Condensed Consolidated Statements of Cash Flows for the nine months ended Septem ber 30, 2024 and 2023 7 Condensed Consolidated Statements of Shareholders' Equity for the three and nine months ended September 30, 2024 and 2023 8 Notes to Condensed Consolidated Financial Statements 9 3 Table of Contents IMAX CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands of U.S. Dollars, except share amounts) (Unaudited) September 30, December 31, 2024 2023 Assets Cash and cash equivalents $ 104,504 $ 76,200 Accounts receivable, net of allowance for credit losses 114,193 136,259 Financing receivables, net of allowance for credit losses 123,459 127,154 Variable consideration receivables, net of allowance for credit losses 74,487 64,338 Inventories 37,612 31,584 Prepaid expenses 13,310 12,345 Film assets, net of accumulated amortization 9,127 6,786 Property, plant and equipment, net of accumulated depreciation 245,106 243,299 Other assets 22,981 20,879 Deferred income tax assets, net of valuation allowance 15,687 7,988 Goodwill 52,815 52,815 Other intangible assets, net of accumulated amortization 34,279 35,022 Total assets $ 847,560 $ 814,669 Liabilities Accounts payable $ 26,018 $ 26,386 Accrued and other liabilities 111,283 111,013 Deferred revenue 53,676 67,105 Revolving credit facility borrowings, net of unamortized debt issuance costs 46,239 22,924 Convertible notes and other borrowings, net of unamortized discounts and debt issuance costs 230,038 229,131 D